A comparison of the uniformity requirements for SPECT image reconstruction using FBP and OSEM techniques.

OBJECTIVE: Gamma camera nonuniformity can result in the presence of ring artifacts in reconstructed SPECT images. The objective of this study is to compare the relationship between ring artifact magnitude and image noise in tomographic images reconstructed using FBP and OSEM. METHODS: A cylindrical phantom was filled with water and (99m)TC: Seven tomographic acquisitions were performed, with total counts per acquisition ranging from 1.5 Mcts to 100 MCTS: All acquisitions were reconstructed using both FBP and OSEM. Ring artifacts were generated in the transaxial data by introducing defects at a given location in each planar image. The modified acquisitions were again reconstructed using both FBP and OSEM. The ring artifacts were isolated by the subtraction of the uncorrupted datasets from the corrupted datasets. The magnitude of the ring artifacts in the corrupted reconstructions was measured and compared to the mean counts and noise level in the uncorrupted data. RESULTS: Ring magnitude in OSEM-reconstructed images is approximately one third that of FBP images. However, there is a corresponding reduction in image noise with OSEM and the ratio of ring magnitude-to-image noise was relatively similar for both OSEM and FBP. Rings generated with OSEM fell off more rapidly with distance from the image center, and reached a plateau at a higher magnitude at large distances. The visibility of rings with OSEM relative to FBP will depend on the location of the causative defect in the planar data and the number of iterations performed with OSEM. Differences between the 2 algorithms are subtle. CONCLUSION: Our results would indicate that the uniformity requirements for SPECT are similar for FBP and OSEM reconstruction algorithms.

Assessment of infarct size and severity by quantitative myocardial SPECT: results from a multicenter study using a cardiac phantom.

UNLABELLED: The aim of this study was to determine the reproducibility of measurements of the size and severity of myocardial defects from 99mTc sestamibi cardiac phantom studies performed on multiple different gamma camera systems. METHODS: A total of 250 gamma camera systems were evaluated over a 5-y period as part of the validation process of multiple multicenter trials. Each laboratory performed 9 acquisitions of a cardiac phantom. Small myocardial defects (0%-30% of myocardial mass) were placed in the inferobasal region, whereas larger defects (40%-70%) were located in the anterior wall. Five representative short-axis slices were analyzed to determine defect size and severity (i.e., contrast in defect region) using circumferential short-axis count profiles. Defect size and severity were analyzed as a function of the type of collimator, gamma camera system, and type of orbit (180degrees versus 360degrees). RESULTS: Of the 250 systems, image data were acquired correctly and showed an acceptable correlation between true and measured defect size in 198 systems. For these systems, the slope of the regression line between true and measured defect size was 1.03 +/- 0.03, with an average absolute error in estimating defect size of 1.7% +/- 0.5% and a correlation coefficient r = 0.99 +/- 0.01. Results were independent of the gamma camera system, type of collimator, and orbit. Contrast in the defect region (minimum count/maximum count) showed a small dependence on collimator resolution and pixel size but was altered significantly by the type of acquisition orbit, with a 360 degrees orbit showing better contrast for defects located in the inferobasal wall than a 180degrees orbit. CONCLUSION: Measurement of defect size is independent of the gamma camera system, type of collimator, and orbit. Contrast in small defects located in the inferobasal wall of the heart is affected significantly by the type of acquisition orbit but not by the type of collimator.

Quantitation of iodine-123-beta-CIT dopamine receptor uptake in a phantom model.

OBJECTIVE: The purpose of this study was to determine the effects of technical factors such as collimation and filtration on the measurement of 123I-beta-CIT uptake in the striatum. METHODS: All SPECT studies were performed using a brain phantom containing striata within a bone- and tissue-equivalent skull. The effects of collimator resolution and septal penetration were assessed from 99mTc and 123I studies containing variable activities in the striata and background regions. Optimum attenuation coefficients (mu) were determined from studies containing uniform activity in the brain. RESULTS: For 99mTc, mu was 0.095 cm-1 and 0.07 cm-1 for parallel-hole and fanbeam collimators, respectively. For 123I, these values dropped to 0.09 cm-1 and 0.00 cm-1 (zero) for medium-energy and fanbeam collimators, respectively. Striatal uptake was significantly underestimated, particularly for medium-energy and general-purpose collimators. With 99mTc, fanbeam collimation gave a 50% increase in the measured striatal uptake, compared to medium-energy collimation. However, with 123I, this gain was eliminated by septal penetration and scatter. Increasing transaxial slice thickness, ROI size and decreasing filter cutoff frequency all degraded apparent striatal uptake. CONCLUSION: Partial volume effects, combined with the averaging effects of increasing slice thickness and ROI size, are the most significant factors affecting measurement of striatal uptake of 123I-beta-CIT. The increased resolution of low-energy high-resolution collimators, compared to a medium-energy collimator, is offset by the increased septal penetration and scatter.

In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines.

Paclitaxel (PTXL) (Taxol), a taxane, and vinorelbine (VRB), a semisynthetic vinca alkaloid drug, have tubulin as their common intracellular target, but inhibit growth by binding to different sites. We evaluated in vitro the antiproliferative activity of these two drugs as single agents and in combination, against two human melanoma cell lines, G361 and StM111a. The SRB (sulphorhodamine B) assay was used to determine growth inhibition. Possible drug-drug interaction at the cellular level was assessed by constructing Isoboles (Isobologram analysis) and applying the concept of an 'envelope of additivity'. Both agents were active in the nanomolar range at clinically achievable concentrations. The mean IC50 for G361 was 46.6 nM (PTXL) and 19.9 nM (VRB) after a 1 h drug exposure. Mean IC50 (1 h) for StM111a was 9.7 nM (PTXL) and 26.9 nM (VRB). Isobole analysis at the isoeffect levels of 25%, 50% and 75% indicated that drug interaction was predominantly synergistic (supra-additive) when paclitaxel and VRB were added concurrently for 1 h to cultures of StM11 1a or G361. In some experiments, this synergy was observed with particularly low concentrations of paclitaxel (3 nM) and VRB (0.01 nM). A new points were located within the envelope of additivity or in the subadditive (antagonism) region of the isobole. An overall synergy was also found if the data were analysed by the median effect analysis. The effect of these agents on the cytoskeleton and ultrastructure were studied with immunofluorescence and electron microscopy, respectively. These results confirm the in vitro inhibitory activity of paclitaxel and VRB against malignant melanoma, but more importantly the two drugs appear to act synergistically at relatively low concentrations.

Penicillinase-producing Neisseria gonorrhoea as a cause of neonatal and adult ophthalmia.

A retrospective analysis of 80 cases of gonococcal ophthalmia revealed six (7.5%) to be due to penicillinase-producing Neisseria gonorrhoeae (PPNG), five neonatal cases and one adult. All six cases were finally cured, but best results were obtained with topical chloramphenicol and single-dose spectinomycin (40 mg/kg) given intramuscularly. All gonococcal isolates should be tested promptly for penicillinase production, and if this is present systemic treatment, modified to spectinomycin or penicillinase-stable cephalosporin, should be given as single-dose treatment.

SPECT imaging of 131I (364 keV): importance of collimation.

A low sensitivity medium energy collimator (LSMEC) designed with thick septa and long bore (theoretical leakage less than 3% 364 keV), was evaluated using 131I for a SPECT system operated in both planar and tomographic imaging modes. The collimator was designed to minimize the influence of photon penetration on spatial resolution, in particular the resolution index FWTM. Overall spatial resolution for the planar imaging mode at 10 cm from the collimator face was found to be 11.6 mm FWHM and 21.6 mm FWHM. The corresponding transverse plane and slice thickness resolution was of the order of 17 mm FWHM and 31 mm FWTM, for a radius of rotation of 16 cm. A SPECT resolution phantom was imaged. Two quadrants of cold rods were well resolved, with rod dimensions of 16 and 12.7 mm respectively, the resolution being comparable to that obtained using 99Tcm (140 keV) and a low-energy high-resolution collimator. NEMA sensitivity obtained was 75 cpm/microCi 131I. The resolution measurements obtained suggest that this collimator should be useful for SPECT imaging with 131I in either radioimmunoimaging or radioimmunotherapy.